NASDAQ Composite Index

NASDAQ Composite Index handeln
25.297,62 PKT -60,99 PKT -0,24 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 969427

ISIN XC0009694271


Analysen zu NASDAQ Composite Index-Werten

Datum Rating Analyst
25.05.11 Applied Materials buy Stifel, Nicolaus & Co., Inc.
25.05.11 Apple outperform Wedbush Morgan Securities Inc.
25.05.11 Apple overweight Barclays Capital
24.05.11 Microsoft sell Jyske Bank Group
24.05.11 Applied Materials overweight Barclays Capital
24.05.11 Amgen kaufen Independent Research GmbH
23.05.11 ESCO Technologies outperform Oppenheimer & Co. Inc.
23.05.11 Silicon Laboratories buy Needham & Company, LLC
23.05.11 Intuit overweight Barclays Capital
23.05.11 Autodesk overweight Barclays Capital
23.05.11 Teva Pharmaceutical Industries kaufen Die Actien-Börse
23.05.11 American Eagle Outfitters hold Needham & Company, LLC
20.05.11 NVIDIA kaufen Nasd@q Inside
20.05.11 Intuit neutral UBS AG
20.05.11 Intel sell Goldman Sachs Group Inc.
20.05.11 Salesforce buy UBS AG
20.05.11 Autodesk buy UBS AG
20.05.11 Nissan Motor kaufen Fuchsbriefe
20.05.11 Autodesk overweight Barclays Capital
20.05.11 NetApp neutral Credit Suisse Group
20.05.11 Applied Materials neutral Goldman Sachs Group Inc.
20.05.11 Lam Research buy Goldman Sachs Group Inc.
20.05.11 KLA sell Goldman Sachs Group Inc.
19.05.11 ABIOMED outperform Wedbush Morgan Securities Inc.
19.05.11 Intel overweight JP Morgan Chase & Co.
19.05.11 Intuit overweight Barclays Capital
19.05.11 Amgen outperform Oppenheimer & Co. Inc.
19.05.11 Intel buy Citigroup Corp.
19.05.11 Intel outperform Credit Suisse Group
19.05.11 Intel buy Needham & Company, LLC
19.05.11 Photronics buy Needham & Company, LLC
18.05.11 Autodesk neutral Credit Suisse Group
18.05.11 Intel buy UBS AG
18.05.11 Apple overweight Barclays Capital
18.05.11 Ceragon Networks overweight Barclays Capital
18.05.11 Alexion Pharmaceuticals buy Goldman Sachs Group Inc.
17.05.11 Intel buy UBS AG
17.05.11 Amgen overweight JP Morgan Chase & Co.
17.05.11 Teva Pharmaceutical Industries buy Citigroup Corp.
17.05.11 Gilead Sciences hold Citigroup Corp.